STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

CUSIP: 34385P108

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 7 signals
Share change
-1,209,178
Put/Call ratio
70%
SEC-reported price per share
$6.00
Number of holders
143
Value change
-$13,720,267
Number of buys
86
Open additional details 1 more signal available
Number of sells
56
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
390,636,209

Security key

34385P108

Report period

Q4 2020

Institutions

143

Top holders

10

Ownership snapshot

Top reported holders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRIMECAP MANAGEMENT CO/CA/
Disclosed value leader
PRIMECAP MANAGEMENT CO/CA/
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F Lead comparable stake: 1.4% Showing 1-6 of 15 holder rows.

Quick read

PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 1.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Comparable ownership Top 5
PRIMECAP MANAGEMENT CO/CA/ 1.4%
BlackRock Finance, Inc. 1.4%
Neuberger Berman Group LLC 1.1%
Indaba Capital Management, L.P. 1%
ORBIMED ADVISORS LLC 0.91%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
1.4%
$41,994,000
5,651,943 shares
30 Sep 2020
BlackRock Finance, Inc.
13F
Company
13F
1.4%
$39,876,000
5,366,967 shares
30 Sep 2020
Neuberger Berman Group LLC
13F
Company
13F
1.1%
$32,366,000
4,362,609 shares
30 Sep 2020
Indaba Capital Management, L.P.
13F
Company
13F
1%
$29,451,000
3,963,752 shares
30 Sep 2020
ORBIMED ADVISORS LLC
13F
Company
13F
0.91%
$26,404,000
3,553,703 shares
30 Sep 2020
VANGUARD GROUP INC
13F
Company
13F
0.9%
$26,222,000
3,529,275 shares
30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
143
Shares
65,301,638
Rows available
143
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
131
Q4 2020 holders
143
Holder diff
12
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .